Insert HTML here
DOTA-CXCR4-L is a CXCR4 targeting peptide. DOTA-CXCR4-L can be used in the study of cancers, including glioblastoma and triple-negative breast cancer. NODAGA-LM3 can be labeled with / for the synthesis/research of Radionuclide-Drug Conjugates (RDCs).
| Product Name | DOTA-CXCR4-L |
| Molecular Weight | 1223.34 |
| Formula | C58H78N16O14 |
| Sequence | cyclo |
| Sequence Shortening | cyclo |
We use cookies to improve your experience on our site. By using our site, you consent to cookies.
Manage your cookie preferences below:
Essential cookies enable basic functions and are necessary for the proper function of the website.
Google Tag Manager simplifies the management of marketing tags on your website without code changes.
Statistics cookies collect information anonymously. This information helps us understand how visitors use our website.
Google Analytics is a powerful tool that tracks and analyzes website traffic for informed marketing decisions.
Service URL: policies.google.com (opens in a new window)
QYAOBIO
Typically replies within minutes
Any questions related to DOTA-CXCR4-L?
WhatsApp Us
Online | Privacy policy
WhatsApp us